Recordati Pharmaceuticals Limited

Isis House, 43 Station Road, Henley-on-Thames, Oxfordshire, RG9 1AT, UK
Telephone: +44 (0)1491 576 336
Fax: +44 (0)1491 576 336
WWW: http://www.recordati.com
Medical Information Direct Line: +44 (0)1491 576 336
Medical Information e-mail: medinfo@recordati.co.uk

Summary of Product Characteristics last updated on the eMC: 22/10/2010
SPC Urispas 200mg Film-coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/10/2010 and displayed until Current
Reasons for adding or updating:
  • Change to MA holder contact details
Date of revision of text on the SPC:   09-Jun-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

New address for Recordati Pharmaceuticals:

Recordati Pharmaceuticals Limited

Isis House

43 Station Road

Henley-on-Thames

Oxfordshire RG9 1AT

United Kingdom

Updated on 12/09/2007 and displayed until 22/10/2010
Reasons for adding or updating:
  • Change of Marketing Authorisation Holder
Date of revision of text on the SPC:   04/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

No changes to the text of the SPC.  This is a change of Marketing Authorisation Holder.
Updated on 03/04/2007 and displayed until 12/09/2007
Reasons for adding or updating:
  • Change of distributor for the product
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   flavoxate hydrochloride